Citations

Mayo Clinic

Showing 10 of 108602 citations.

EZH2 and histone deacetylase inhibitors induce apoptosis in triple negative breast cancer cells by differentially increasing H3 Lys27 acetylation in the BIM gene promoter and enhancers
Huang, Julia, Ling, Kun , Huang, Julia P, Huang, Julia

Oncology Letters | September 8, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3892/ol.2017.6912 | PMID 29113202 Get It

Human Papillomavirus Vaccine and Postural Orthostatic Tachycardia Syndrome: A Review of Current Literature
Butts, Breann N. , Mack, Kenneth J. , Fischer, Philip R. , Butts, Breann N.

Journal of Child Neurology | September 8, 2017 | Volume: 32 | Issue: 11 | Pages: 956-965

10.1177/0883073817718731 | PMID 28689455 Get It

The human papillomavirus (HPV) vaccine is efficacious in preventing complications of human papillomavirus infection including cervical cancer. However, there have been case reports of adverse events occurring after vaccination, one being postural orthostatic tachycardia syndrome (POTS). This article reviews published data and other available information regarding the relationship between the human papillomavirus vaccine and POTS. Background information is provided regarding the human papillomavirus vaccine and the proposed post-vaccination adverse event POTS. Peer-reviewed literature, statements by government and medical advisory committees, and publicly available information published on this topic are examined. At this time, there is no conclusive evidence supporting a causal relationship between the human papillomavirus vaccine and POTS. Though a causal relationship has been postulated, it is of utmost importance to recognize that while temporal associations may be observed, conclusions of causality cannot be drawn from case reports and case series due to the small sample size and lack of control population.
Early Diagnosis and Treatment of Lennox-Gastaut Syndrome
Resnick, Trevor, Sheth, Raj D.

Journal of Child Neurology | September 8, 2017 | Volume: 32 | Issue: 11 | Pages: 947-955

10.1177/0883073817714394 | PMID 28689466 Get It

Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with high morbidity and mortality. The peak period for manifestations of Lennox-Gastaut syndrome is between ages 3 and 5 years, a time of critical brain development and corresponding vulnerability to the electroclinical dysfunction arising from Lennox-Gastaut syndrome. Diagnosis is based on a triad of symptoms: multiple seizure types, cognitive impairment, and slow spike-and-wave pattern on electroencephalography. In practice, Lennox-Gastaut syndrome presentation is diverse, and there may be a delay between initial symptoms and emergence of the full triad of clinical features. Additionally, differential diagnosis is complicated by the resemblance of Lennox-Gastaut syndrome to other forms of epilepsy and by the need for varied diagnostic techniques requiring specific clinical skills. Because diagnosis is complex and early intervention may lead to improved outcomes, clinicians should consider treatment when Lennox-Gastaut syndrome symptoms are present, even in the absence of a formal diagnosis.
Reply to Letter to the Editor: Paget's Disease of the Temporal Bone: A Single-Institution Contemporary Review of 27 Patients
Deep, Nicholas L. , Besch‐Stokes, Jake , Lane, John I. , Driscoll, Colin L. W., Carlson, Matthew L. , Besch-Stokes, J G

Otology & Neurotology | September 7, 2017 | Volume: 38 | Issue: 10 | Pages: 1547-1548

10.1097/mao.0000000000001562 | PMID 28891874 Get It

Autosomal dominant calpainopathy due to heterozygous CAPN3 C.643_663del21
Martinez‐Thompson, Jennifer M. , Niu, Zhiyv , Tracy, Jennifer A., Moore, Steven A. , Swenson, Andrea , Wieben, Eric D. , Milone, Margherita , Niu, Zhiyv

Muscle & Nerve | September 7, 2017 | Volume: 57 | Issue: 4 | Pages: 679-683

10.1002/mus.25970 | PMID 28881388 Get It

ABSTRACTIntroduction: A calpain‐3 (CAPN3) gene heterozygous deletion (c.643_663del21) was recently linked to autosomal dominant (AD) limb‐girdle muscular dystrophy. However, the possibility of digenic disease was raised. We describe 3 families with AD calpainopathy carrying this isolated mutation. Methods: Probands heterozygous for CAPN3 c.643_663del21 were identified by targeted next generation or whole exome sequencing. Clinical findings were collected for probands and families. Calpain‐3 muscle Western blots were performed in 3 unrelated individuals. Results: Probands reported variable weakness in their 40s or 50s, with myalgia, back pain, or hyperlordosis. Pelvic girdle muscles were affected with adductor and hamstring sparing. Creatine kinase was normal to 1,800 U/L, independent of weakness severity. Imaging demonstrated lumbar paraspinal muscle atrophy. Electromyographic findings and muscle biopsies were normal to mildly myopathic. Muscle calpain‐3 expression was reduced. Discussion: This study provides further evidence for AD calpainopathy associated with CAPN3 c.643_663del21. No pathogenic variants in other genes known to cause myopathy were detected. Muscle Nerve 57: 679–683, 2018
How to deal with Keratokonus – are there Contact Lens Related Problems in Sclerals?
Nau, Cherie B. , Nau, Amy , Harthan, Jennifer , Shorter, Ellen , Fogt, Jennifer Swingle , Schornack, Muriel

Acta Ophthalmologica | September 7, 2017 | Volume: 95 | Issue: S259 | Pages: No page available

10.1111/j.1755-3768.2017.03574 Get It

SummaryScleral lenses have become a popular early treatment choice for patients with keratoconus. In a recent SCOPE (Scleral Lenses in Current Ophthalmic Practice: an Evaluation) study group finding, 34% of practitioners, of 629 survey respondents, chose scleral lenses as their first treatment option for patients with corneal irregularity. Among all treatment choices for corneal irregularity, scleral lenses ranked second only to corneal rigid gas permeable lenses, from those responding. The SCOPE study group then polled a group of keratoconus patients wearing scleral lenses. Of 79 keratoconus patients reporting scleral lens wear in both eyes, 85% were somewhat or very satisfied with their vision. However, these patients also reported experiencing cloudy vision (59%), lens discomfort (67%), and difficulty with lens handling (63%) at some time over the previous two years.
An adult with a rare form of congenital fiber type disproportion
Anandan, Charenya, Milone, Margherita

Muscle & Nerve | September 7, 2017 | Volume: 57 | Issue: 1 | Pages: No page available

10.1002/mus.25954 | PMID 28881016 Get It

Brief Report: A Novel ELANE Mutation Associated With Inflammatory Arthritis, Defective NETosis, and Recurrent Parvovirus Infection
Thanarajasingam, Uma , Jensen, Mark A. , Dorschner, Jessica M., Muskardin, Theresa Wampler , Ghodke‐Puranik, Yogita , Purmalek, Monica , Eliopoulos, Elias , Zervou, Maria I. , Goulielmos, George N. , Howard, Matthew T., Kaplan, Mariana J. , Niewold, Timothy B. , Howard, Matthew

Arthritis & Rheumatology | September 7, 2017 | Volume: 69 | Issue: 12 | Pages: 2396-2401

10.1002/art.40314 | PMID 28881492 Get It

ObjectiveWe describe a 38‐year‐old woman who presented with a history of inflammatory arthritis, rash, and daily fevers. She was noted to have chronic parvovirus infection with persistently detectable viral titers and a novel mutation in the ELANE gene. ELANE encodes neutrophil elastase, a neutrophil serine protease with important antimicrobial effects, and is found as part of neutrophil extracellular trap (NET) complexes. Pathogenic ELANE mutations have been identified in forms of hereditary neutropenia. However, our patient never had neutropenia. Because of the striking clinical scenario, we investigated this mutation functionally.MethodsNET formation by neutrophils was assessed by scanning electron microscopy. Neutrophil activation and neutrophil elastase production were evaluated by flow cytometry and fluorescent substrate–based functional assay, respectively. A multiplex assay was used to quantitate neutrophil inflammatory cytokine production. PyMOL software was used to generate 3‐dimensional models of mutant elastase.ResultsActivated neutrophils from the patient demonstrated a significantly decreased ability to form NETs on scanning electron microscopy, as well as quantitative defects in neutrophil activation and neutrophil elastase activity. The patient's neutrophils showed altered levels of interleukin‐12 (IL‐12) and IL‐8, which are key cytokines for antiviral immunity and neutrophil chemotaxis. Three‐dimensional mapping revealed that the mutation could alter protein folding and surface charge distribution, potentially perturbing protein trafficking. Thus, the mutation could affect neutrophil function by decreasing NETosis and altering key antiviral activities of neutrophils.ConclusionThis is the first report of a human pathogenic ELANE mutation associated with a defect in NETosis and a distinct syndrome of recurrent viral infection and chronic inflammation.
Immortal Time Bias: Comment on the Article by Gwinnutt et al
Crowson, Cynthia S.

Arthritis & Rheumatology | September 7, 2017 | Volume: 69 | Issue: 12 | Pages: 2402-2402

10.1002/art.40312 | PMID 28881499 Get It

The Epidemiology of Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis in Olmsted County, Minnesota
Berti, Alvise , Crowson, Cynthia S. , Matteson, Eric L. , Cornec, Divi, Berti, Alvise , Cornec, Divi , Specks, Ulrich

Arthritis & Rheumatology | September 7, 2017 | Volume: 69 | Issue: 12 | Pages: 2338-2350

10.1002/art.40313 | PMID 28881446 Get It

ObjectiveTo estimate the annual incidence, prevalence, and mortality of antineutrophil cytoplasmic autoantibody (ANCA)–associated vasculitis (AAV) and its subsets, granulomatosis with polyangiitis (Wegener's) (GPA), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (Churg‐Strauss) (EGPA), in a US‐based adult population.MethodsAll medical records of patients with a diagnosis of, or suspicion of having, AAV in Olmsted County, Minnesota from January 1, 1996 to December 31, 2015 were reviewed. AAV incidence rates were age‐ and sex‐adjusted to the 2010 US white population. Age‐ and sex‐adjusted prevalence of AAV was calculated on January 1, 2015. Survival rates observed in the study cohort were compared with expected rates in the Minnesota population.ResultsOf the 58 incident cases of AAV in Olmsted County during the study period, 23 (40%) were cases of GPA, 28 (48%) were cases of MPA, and 7 (12%) were cases of EGPA. Overall, 28 (48%) of the patients with AAV were women and 57 (98%) were white. The mean ± SD age at diagnosis was 61.1 ± 16.5 years. Thirty‐four patients (61%) had myeloperoxidase (MPO)–ANCAs, and 17 (30%) were positive for proteinase 3 (PR3)–ANCAs; 5 (9%) were ANCA‐negative. The annual incidence of AAV was 3.3 per 100,000 population (95% confidence interval [95% CI] 2.4–4.1). The incidence rates of GPA, MPA, and EGPA were 1.3 (95% CI 0.8–1.8), 1.6 (95% CI 1.0–2.2), and 0.4 (95% CI 0.1–0.6), respectively. The overall prevalence of AAV was 42.1 per 100,000 (95% CI 29.6–54.6). The mortality rate among AAV patients overall, and among patients with EGPA, those with MPA, and those with MPO‐ANCAs, was increased in comparison to the Minnesota general population (each P < 0.05), whereas mortality rates among patients with GPA, those with PR3‐ANCAs, and ANCA‐negative patients did not differ from that in the general population.ConclusionThe annual incidence of AAV in Olmsted County, Minnesota over the 20 years of the study was 3.3 per 100,000, with a prevalence of 42.1 per 100,000, which is substantially higher than the rates reported in other areas worldwide. The incidence of GPA was similar to that of MPA. Patients with MPA and those with EGPA, but not patients with GPA, experienced higher rates of mortality than that in the Minnesota general population. MPO‐ANCAs were a marker of poor survival in this population of patients with AAV.